XORTX Therapeutics Inc.
XRTX • NASDAQ
XORTX Therapeutics Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Allen Warren Davidoff, with a market cap of $2.6M.
CEOAllen Warren Davidoff
Next Earnings
Upcoming earnings announcement for XORTX Therapeutics Inc.
Date
Friday, May 15, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
Earnings History
Past 12 earnings reports for XORTX Therapeutics Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 17, 2025 | Q3 2025 | -$0.13Est: -$0.32 | +59.4% | - | — | — |
| Aug 15, 2025 | Q2 2025 | -$0.19 | — | - | — | — |
| May 16, 2025 | Q1 2025 | -$0.19 | — | - | — | — |
| Mar 21, 2025 | Q4 2024 | -$0.04 | — | - | — | — |
| Nov 15, 2024 | Q3 2024 | -$0.20 | — | - | — | — |
| Aug 14, 2024 | Q2 2024 | $0.06 | — | - | — | — |
| May 17, 2024 | Q1 2024 | -$1.24 | — | - | — | — |
| May 10, 2024 | Q4 2023 | $1.36Est: -$0.44 | +409.1% | - | — | — |
| Nov 16, 2023 | Q3 2023 | -$0.67Est: -$0.19 | -252.6% | - | — | — |
| Aug 15, 2023 | Q2 2023 | -$0.81 | — | - | — | — |
| May 16, 2023 | Q1 2023 | -$0.99 | — | - | — | — |
| Apr 3, 2023 | Q4 2022 | -$1.35Est: -$1.44 | +6.2% | - | — | — |